Direxion Daily S&P Biotech Bear 3X ETF
LABD
18 hedge funds and large institutions have $30.9M invested in Direxion Daily S&P Biotech Bear 3X ETF in 2020 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 6 increasing their positions, 0 reducing their positions, and 1 closing their positions.
1,000% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 1
125% more funds holding
Funds holding: 8 → 18 (+10)
51% more capital invested
Capital invested by funds: $20.5M → $30.9M (+$10.4M)
0.02% less ownership
Funds ownership: 0.19% → 0.17% (-0.02%)
25% less call options, than puts
Call options by funds: $1.89M | Put options by funds: $2.53M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BC
Boxer Capital
San Diego,
California
|
+$36.1M |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
+$3.62M |
| 3 |
HF
HRT Financial
New York
|
+$2.6M |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$1.46M |
| 5 |
FTUS
Flow Traders U.S.
New York
|
+$888K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FLAM
First Light Asset Management
Edina,
Minnesota
|
-$217K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$1K |
LABD Hedge Fund Activity: Q2 2020 in Review
18 of the 4,878 institutional investors tracked by Wall St. Rank reported a position in Direxion Daily S&P Biotech Bear 3X ETF (LABD) for Q2 2020, worth a combined $30.9M — up 51% from $20.5M a quarter earlier.
Buyers outnumbered sellers: 11 funds opened new LABD positions and 1 closed out — a net gain of 10 holders — while 6 added to existing stakes and 0 trimmed.
The largest buyer was Boxer Capital, adding an estimated $36.1M. The largest seller was First Light Asset Management, exiting entirely with an estimated $217K sold.
- 18 institutional investors held Direxion Daily S&P Biotech Bear 3X ETF (LABD) as of Q2 2020, up from 8 in Q1 2020.
- Funds reported $30.9M of Direxion Daily S&P Biotech Bear 3X ETF stock for Q2 2020, up 51% quarter-over-quarter.
- 11 funds opened new Direxion Daily S&P Biotech Bear 3X ETF positions in Q2 2020 and 1 closed out, a net change of +10 holders.
- The largest Direxion Daily S&P Biotech Bear 3X ETF buyer in Q2 2020 was Boxer Capital, an estimated $36.1M added.
- The largest Direxion Daily S&P Biotech Bear 3X ETF seller in Q2 2020 was First Light Asset Management, an estimated $217K sold.
Based on aggregated 13F filings for Q2 2020.